Michael Sørensen

Regional metabolic liver function measured in patients with cirrhosis by 2-[¹⁸F]fluoro-2-deoxy-D-galactose PET/CT

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

There is a clinical need for methods that can quantify regional hepatic function non-invasively in patients with cirrhosis. Here we validate the use of 2-[(18)F]fluoro-2-deoxy-d-galactose (FDGal) PET/CT for measuring regional metabolic function to this purpose, and apply the method to test the hypothesis of increased intrahepatic metabolic heterogeneity in cirrhosis.
Original languageEnglish
JournalJournal of Hepatology
Volume58
Issue6
Pages (from-to)1119-24
Number of pages6
ISSN0168-8278
DOIs
Publication statusPublished - Jun 2013

See relations at Aarhus University Citationformats

ID: 68449599